You are here

Agency Actions

Despite Savings from Pilot Programs, Medicaid Costs Have Soared
New Draft Guidance Seeks to Better Target Patient Needs
Quality Metrics Will Provide Feedback to Manufacturers
Some see the loss of an important, unbiased source of information.
One of the proposed changes makes remote patient monitoring an allowable cost.
FDA questioning the pharmacokinetics of psoriasis lotion Duobrii
Guidance published on how to best design coverage for treatment of the smallest, most vulnerable victims of the opioid crisis
Agent being studied to combat vulvovaginal candidiasis
Agency aims to ensure women are properly informed of the risks